Skip to content

Medical Weight Loss

Tirzepatide

A dual-agonist GLP-1 / GIP program for patients seeking advanced metabolic results — physician-directed, concierge-supported, transparently priced.

Clinical Average~20% body weight
7
AvailabilityTelehealth nationwide
Request Consultation

By private consultation

Sterling Private Medical Tirzepatide program — clinical still life
Sterling

Clinical Overview

How Tirzepatide works

The first medication in its class to engage two metabolic pathways at once — and the reason its trial outcomes set a new ceiling.

Engages two metabolic pathways simultaneously
Highest average weight loss recorded in published GLP-1-class trials
Strong, closely monitored response under physician direction
Active Biological Mechanisms
Stage 01

Engages the GIP receptor

Targets glucose-dependent insulinotropic polypeptide — a metabolic pathway most weight-management medications do not address.

Stage 02

Engages the GLP-1 receptor

Simultaneously mimics GLP-1 — suppressing appetite and slowing how quickly food leaves the stomach.

Stage 03

Combined metabolic effect

The dual mechanism produces the highest average weight loss recorded in any GLP-1-class clinical trial to date.

Candidacy Profiling

A considered fit, not a funnel.

Adults seeking the most advanced GLP-1-class protocol, with the supervision and titration discipline this medication deserves.

Optimal Candidate
  • Adults 18+ with a BMI of 27 or higher, or 25+ with weight-related conditions
  • Patients who have plateaued on a single-agonist GLP-1 and want to escalate under supervision
  • Those for whom faster onset and higher trial averages are clinically appropriate
Clinical Exclusion
  • Personal or family history of medullary thyroid carcinoma or MEN 2
  • Pregnancy, breastfeeding, or planning pregnancy
  • Active pancreatitis or untreated severe gastrointestinal disease

Expected Timeline

What to Expect

Tirzepatide tends to act faster and reach further than single-agonist GLP-1s. Your physician titrates carefully to the dose that fits your body.

  1. 01

    Month 1

    Titration

    Faster initial response than single-agonist GLP-1s. Careful dose escalation begins.

  2. 02

    Month 3

    Established

    Therapeutic dose reached. Strong metabolic momentum; appetite consistently reduced.

  3. 03

    Month 6

    ~20%

    Average body weight reduction in published trials. Many patients exceed this range.

  4. 04

    Year 1+

    Sustained

    Sustained reduction for the majority of patients who remain in the program.

Outcomes referenced from SURMOUNT-1 trial data. Individual results depend on starting weight, dose, and adherence.

Sterling Private Medical concierge care

Your Concierge Support

A licensed clinician, matched to you.

Sterling is built on access. Your care is directed by a licensed physician and supported by a concierge team that knows your name and your history — reachable through secure messaging on your schedule, around the clock. You are looked after by people, not routed through a call center.

What's Included in your Flat-Rate Program
01Compounded medication
Prepared by partner compounding pharmacies in the USA and shipped on a structured cadence.
02Your own physician
Care is directed by a licensed physician who knows your history — not a rotating call center.
03Physician-directed dosing
Titration and adjustments at every transition under careful clinical supervision.
04Around-the-clock messaging
Reach your care team between check-ins through your secure, private patient portal.
05Structured check-ins
Cadenced reviews that keep your protocol and wider plan calibrated to your response.
06Discreet direct delivery
Temperature-controlled, unmarked packaging delivered straight to your door.

Clinical Safety

No medication is right for everyone.

01

Common side effects

Most common during titration: nausea, decreased appetite, and digestive changes. Typically mild and resolve as the body adjusts to each step in the protocol.

02

Clinical Contraindications

Not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2, or for patients who are pregnant or breastfeeding. Full medical history is reviewed before any prescription is authorized.

Clinical Experience

From members of the Tirzepatide program.

  • I had plateaued for months. The move to Tirzepatide was a second wind — down another twenty-two pounds in four months, and my physician walked me through every step.

    David L.

    Sterling patient · transitioned from Semaglutide

  • The speed surprised me. By week three I was setting reminders to eat. My energy is up, my labs are the best they have been in a decade, and the team is always a message away.

    Priya N.

    Sterling patient · 5 months on Tirzepatide

  • I wanted to know someone was actually paying attention to me, not a queue. At Sterling that is exactly what I got — and the results speak for themselves.

    James K.

    Sterling patient · 6 months on Tirzepatide

Frequently Asked

Questions worth asking before you begin.

  • Every program begins with a private online consultation. If your physician authorizes treatment, your protocol is prepared by a partner compounding pharmacy and delivered discreetly to your door, with structured check-ins and around-the-clock messaging access to your care team throughout.

  • Concierge does not mean opaque. Our programs feature flat, transparent pricing with no hidden fees, no consultation charges, and no dose-change surcharges. The price we quote is the price you pay.

  • Sterling is a concierge practice spanning medical weight loss, hormone and vitality care, and healthy-aging protocols for both men and women. Our flagship online programs are physician-directed GLP-1 weight management; broader concierge services are arranged through your physician.

  • Your consultation is reviewed and authorized by a licensed physician. Every patient receives consistent, physician-directed clinical care with private messaging access.

  • Memberships may be canceled with 30 days' notice prior to the next billing cycle. Consultations, medical visits, and fulfilled prescriptions are non-refundable once services begin or medication is processed.

  • Yes. Sterling Private Medical is HIPAA compliant and discretion is built into everything we do. Your medical information is shared only with your physician and the dispensing pharmacy. We never sell or share your data.

Comparison Protocol

Semaglutide

The foundational single-agonist GLP-1 program. Lower trial averages, often the right starting point.

Begin Consultation

The Tirzepatide program begins with a conversation.

Your consultation is reviewed by your dedicated provider. If authorized, your protocol is prepared by a partner compounding pharmacy and delivered direct to your door.